News

Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ETCompany ParticipantsBrian Luque - Head of Investor Relations ...
Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...
a new variation of fraudulent activity has emerged in the form of counterfeit and black-market versions of prescription medications. Falsified semaglutide products have been reported circulating ...
It’s a federally compliant state-issued license or identification card that the DHS says is a more secure form of identification ... at a DMV and what documentation you’ll need when you ...
Keep in mind that VK2735 is a dual-agonist approach that mimics both GLP-1 and GIP pathways, similar to Eli Lilly’s injectable Zepbound, but in oral form. So, one could say that VK2735 could be ...
Empower Pharmacy markets itself as a well-meaning rival to Big Pharma - one that seeks to democratize medicine by making ...
It is now possible, for example, to connect regulatory and quality data and content, particularly product documentation ... 1 agonist semaglutide, ending sales of compounded forms.
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...